Castle Biosciences Equity 2025

Castle Biosciences Aktienanalyse

What does Castle Biosciences do?

Castle Biosciences Inc is an American company that was founded in 2007. The company's goal is to develop and distribute innovative diagnostic tests for various types of cancer. Castle Biosciences is headquartered in Friendswood, Texas, and has numerous branches throughout North America. The company currently has around 200 employees and a strong management team. The business model of Castle Biosciences is based on the development and marketing of personalized medical tests that can help improve the diagnosis and treatment of cancer patients. Castle Biosciences primarily offers its tests through doctors and medical facilities. The company specializes in the development of prognostic and predictive tests that can provide doctors with important information to create personalized treatment plans for their patients. Castle Biosciences has several divisions specializing in different types of cancer. One of the most important divisions is in the field of dermatology, developing and distributing tests for the diagnosis and prognosis of melanoma and other skin cancer types. Castle Biosciences also offers personalized tests for cancer of the eyes, stomach, and lung. Another important product of Castle Biosciences is the DecisionDx-Melanoma test. The test is a molecular diagnostic procedure that predicts the likelihood of melanoma recurrence. The test utilizes proprietary gene expression analysis to assess the risk of melanoma recurrence within five years after tumor removal. The results of the test can help minimize the risk of relapse and improve the patients' quality of life. Castle Biosciences has also developed the DecisionDx-UM test, a diagnostic test for uveal melanoma, a rare cancer affecting the eyes. The DecisionDx-UM test uses RNA expression to predict the individual metastatic risk of the cancer and support optimal medical management. The company has also specialized in the development of tests for gastric cancer. The CastleTest™ analyzes the transcription activity of 11 genes to determine the risk of tumor spread from the primary gastric location. Castle Biosciences has made significant progress in recent years and continues to expand through the introduction of new products and services in the market. The company emphasizes a certification program and continuous training of doctors and pathologists to support test performance. Additionally, Castle Biosciences has brought together additional knowledge and expertise through partnerships with other companies and institutions to develop innovative solutions for a wider range of cancer types. Overall, Castle Biosciences is a company specializing in innovative solutions for the diagnosis and prognosis of cancer. The personalized tests from Castle Biosciences have the potential to improve the quality of life for cancer patients by providing additional information for individual treatment plans. With its dedicated workforce and successful products, Castle Biosciences will continue to play an important role in the fight against cancer. Castle Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Castle Biosciences's Equity

Castle Biosciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Castle Biosciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Castle Biosciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Castle Biosciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Castle Biosciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Castle Biosciences stock

What is the equity of Castle Biosciences this year?

Castle Biosciences has equity of 455.83 M USD this year.

What was the equity of Castle Biosciences compared to the previous year?

The equity of Castle Biosciences has increased/decreased by 16.5% increased compared to the previous year.

What impact does a high equity have on investors of Castle Biosciences?

A high equity is advantageous for investors of Castle Biosciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Castle Biosciences?

A low equity can be a risk for investors of Castle Biosciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Castle Biosciences affect the company?

An increase in equity of Castle Biosciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Castle Biosciences affect the company?

A reduction in equity of Castle Biosciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Castle Biosciences?

Some factors that can affect the equity of Castle Biosciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Castle Biosciences so important for investors?

The equity of Castle Biosciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Castle Biosciences take to change the equity?

To change equity, Castle Biosciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Castle Biosciences pay?

Over the past 12 months, Castle Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Castle Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Castle Biosciences?

The current dividend yield of Castle Biosciences is .

When does Castle Biosciences pay dividends?

Castle Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Castle Biosciences?

Castle Biosciences paid dividends every year for the past 0 years.

What is the dividend of Castle Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Castle Biosciences located?

Castle Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Castle Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Castle Biosciences from 7/12/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/12/2025.

When did Castle Biosciences pay the last dividend?

The last dividend was paid out on 7/12/2025.

What was the dividend of Castle Biosciences in the year 2024?

In the year 2024, Castle Biosciences distributed 0 USD as dividends.

In which currency does Castle Biosciences pay out the dividend?

The dividends of Castle Biosciences are distributed in USD.